Skip to main content

Periodontitis and Liver Diseases

  • Chapter
  • First Online:
Studies on Periodontal Disease

Abstract

Periodontitis, which is a chronic inflammatory disease caused by oral bacterial infection, is considered to be a risk factor for systemic disease. The liver is an important organ closely associated with lipid and glucose metabolism. Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease. In this chapter, the relationship between periodontitis and liver diseases, focusing mainly on NAFLD progression, is summarized. Periodontitis increases the serum lipopolysaccharide level, contributing to liver injury. In addition, clinical and animal studies have shown that periodontal inflammation induces overproduction of lipid peroxide in the periodontal lesion, which is involved in progression of liver diseases. That liver abnormalities may indicate a risk for periodontitis and that periodontitis may be a risk factor for the progression of liver diseases are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Williams RC (1990) Periodontal disease. N Engl J Med 322:373–382

    Article  CAS  PubMed  Google Scholar 

  2. Meley BL, Oates TW (2006) American academy of periodontology: diabetes mellitus and periodontal diseases. J Periodontol 77:1289–1303

    Article  Google Scholar 

  3. Cutler CW, Iacopino AM (2003) Periodontal disease: links with serum lipid/triglyceride levels? Review and new data. J Int Acad Periodontol 5:47–51

    PubMed  Google Scholar 

  4. Morrison HI, Ellison LF, Taylor GW (1999) Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 6:7–11

    CAS  PubMed  Google Scholar 

  5. Sculley DV, Langley-Evans SC (2002) Salivary antioxidants and periodontal disease status. Proc Nutr Soc 61:137–143

    Article  PubMed  Google Scholar 

  6. Valko M, Leibfritz D, Moncol J, Gronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human diseases. Int J Biochem Cell Biol 39:44–84

    Article  CAS  PubMed  Google Scholar 

  7. Cahill A, Wang X, Hoek JB (2004) Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Alcohol 235:49–58

    Google Scholar 

  8. Ekuni D, Tomofuji T, Sanbe T, Irie K, Azuma T, Maruyama T, Tamaki N, Murakami J, Kokeguchi S, Yamamoto T (2009) Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch Oral Biol 54:495–502

    Article  CAS  PubMed  Google Scholar 

  9. Panjamurthy K, Mannoharan S, Ramachandran CR (1999) Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett 10:255–264

    Google Scholar 

  10. Sobaniec H, Sobaniec-Lotowska ME (2000) Morphological examinations of hard tissues of periodontium and evaluation of selected processes of lipid peroxidation in blood serum of rats in the course of experimental periodontitis. Med Sci Monit 6:875–881

    CAS  PubMed  Google Scholar 

  11. Butterfield DA, Bader Lange ML, Sultana R (2010) Involvement of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer’s disease. Biochim Biophys Acta 1801:924–929

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Singh M, Nam DT, Arseneault M, Ramassamy C (2010) Role of by-products of lipid oxidation in Alzheimer’s disease brain: a focus on acrolein. J Alzheimers Dis 21:741–756

    CAS  PubMed  Google Scholar 

  13. Davies SS, Roberts LJ 2nd (2011) F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 50:559–566

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W (2005) F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 24:201–208

    Article  CAS  PubMed  Google Scholar 

  15. Poli G, Biasi F, Leonarduzzi G (2008) 4-Hydroxynonenal-protein adduct: a reliable biomarkers of lipid oxidation in liver diseases. Mol Aspects Med 29:67–71

    Article  CAS  PubMed  Google Scholar 

  16. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A (2006) Relationship between periodontitis and hepatic condition in Japanese women. J Int Acad Periodontol 8:89–95

    PubMed  Google Scholar 

  17. Ohyama H, Nakasho K, Yamanegi K, Noiri Y, Kuhara A, Kato-Kogoe N, Yamada N, Hata M, Nishimura F, Ebisu S, Terada N (2009) An unusual autopsy case of pyogenic liver abscess caused by periodontal bacteria. Jpn J Infect Dis 62:381–383

    PubMed  Google Scholar 

  18. Tomofuji T, Sanbe T, Ekuni D, Azuma T, Irie K, Maruyama T, Tamaki N, Yamamoto T (2008) Oxidative damage of liver induced by ligature-induced periodontitis and chronic ethanol consumption. Arch Oral Biol 53:1113–1118

    Article  CAS  PubMed  Google Scholar 

  19. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 18:1221–1231

    Article  Google Scholar 

  20. Ludwing J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438

    Google Scholar 

  21. Adams LA, Knuiman MW, Divitini ML, Olynyk JK (2008) Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol 23:1089–1093

    Article  CAS  PubMed  Google Scholar 

  22. Liou I, Kowdley KV (2006) Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:511–516

    Google Scholar 

  23. Diehl AM, Goodman Z, Ishak KG (1998) Alcohol-like disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056–1062

    Google Scholar 

  24. Abdelmalek MF, Diehl AM (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91:1125–1149

    Article  CAS  PubMed  Google Scholar 

  25. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini M, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923

    Article  PubMed  Google Scholar 

  26. Stefan N, Haring HU (2011) The metabolically benign and malignant fatty liver. Diabetes 60:2011–2017

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Wierzbicki AS, Oben J (2012) Nonalcoholic fatty liver disease and lipids. Curr Opin Lipidol 23:345–352

    Article  CAS  PubMed  Google Scholar 

  29. Bays HE (2011) Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol 57:2461–2473

    Article  CAS  PubMed  Google Scholar 

  30. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Tarugi P, Averna M (2011) Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem 54:81–107

    Article  CAS  PubMed  Google Scholar 

  32. Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura J, Lifton RP, Shulman GI (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362:1082–1089

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Tailleux A, Wouters K, Staels B (2012) Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821:809–818

    Article  CAS  PubMed  Google Scholar 

  34. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461–1465

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Ye R, Jung DY, Jun JY, Li J, Luo S, Ko HJ, Kim JK, Lee AS (2010) Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59:6–16

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG (2012) The inflammasome puts obesity in the danger zone. Cell Metab 15:10–18

    Article  CAS  PubMed  Google Scholar 

  37. Zhang X, Xu A, Chung SK, Cresser JH, Sweeney G, Wong RL, Lin A, Lam KS (2011) Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 60:486–495

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Bataille AM, Manautou JE (2012) Nrf2: a potential target for new therapeutics in liver disease. Clin Pharmacol Ther 92:340–348

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Rolo AP, Teodoro JS, Palmeira CM (2012) Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52:59–69

    Article  CAS  PubMed  Google Scholar 

  40. Aldaba-Muruato LR, Moreno MG, Shibayama M, Tsutsumi V, Muriel P (2012) Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-kappaB, cytokine production and oxidative stress. Biochim Biophys Acta 1820:65–75

    Article  CAS  PubMed  Google Scholar 

  41. Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG (2011) Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS ONE 6:e24957

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV (1994) Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci U S A 91:12808–12812

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Furuta M, Ekuni D, Yamamoto T, Irie K, Koyama R, Sanbe T, Yamanaka R, Morita M, Kuroki K, Tobe K (2010) Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand 68:27–33

    Article  CAS  PubMed  Google Scholar 

  44. Jaiswal G, Deo V, Bhongrade M, Jaiswal S (2011) Serum alkaline phosphatase: a potential marker in the progression of periodontal disease in cirrhosis patients. Quintessence Int 42:345–348

    PubMed  Google Scholar 

  45. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ (2005) Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 41:426–429

    Article  PubMed  Google Scholar 

  46. Tamaki N, Takaki A, Tomofuji T, Endo Y, Kasuyama K, Ekuni D, Yasunaka T, Yamamoto K, Morita M (2011) Stage of hepatocellular carcinoma is associated with periodontitis. J Clin Periodontol 38:1015–1020

    Article  PubMed  Google Scholar 

  47. Feingold KR, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765–1776

    CAS  PubMed  Google Scholar 

  48. Tomofuji T, Ekuni D, Yamanaka R, Kusano H, Azuma T, Sanbe T, Tamaki N, Yamamoto T, Watanabe T, Miyauchi M, Takata T (2007) Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 78:1999–2006

    Article  CAS  PubMed  Google Scholar 

  49. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772

    Article  CAS  PubMed  Google Scholar 

  50. Saito T, Hayashida H, Furugen R (2007) Metabolic endotoxemia initiates obesity and insulin resistance: diabetes. Diabetes 56:1761–1772, Comment on: Cani et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772

    Article  Google Scholar 

  51. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, Murata S, Tohnai I, Sumida Y, Shima T, Kuboniwa M, Umemura K, Kamisaki Y, Amano A, Okanoue T, Ooshima T, Nakajima A (2012) Involvement of a periodontal pathogen, porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol 12:16

    Article  PubMed Central  PubMed  Google Scholar 

  52. Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, Hisatune J, Kurihara H, Sugai M, Hayes CN, Nakahara T, Aikata H, Takahashi S, Chayama K, Takata T (2013) Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol 48:1259–1270

    Google Scholar 

  53. Yamamoto T, Tomofuji T, Tamaki N, Ekuni D, Azuma T, Sanbe T (2010) Effects of topical application of lipopolysaccharide and proteases on hepatic injury induced by high-cholesterol diet in rats. J Periodontal Res 45:129–135

    Article  CAS  PubMed  Google Scholar 

  54. Schwartz J, Stinson FL, Parker RB (1972) The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J Periodontol 43:270–276

    Article  CAS  PubMed  Google Scholar 

  55. Solga SF, Diehl A (2003) Non-alcoholic fatty liver disease: limen-liver interactions and possible role for probiotics. J Hepatol 38:681–687

    Article  CAS  PubMed  Google Scholar 

  56. Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S (1999) Distribution of porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 37:1426–1430

    CAS  PubMed Central  PubMed  Google Scholar 

  57. Nakagawa I, Amano A, Ohara-Nemoto Y, Endoh N, Morisaki I, Kimura S, Kawabata S, Hamada S (2002) Identification of a new variant of fimA gene of porphyromonas gingivalis and its distribution in adults and disabled populations with periodontitis. J Periodontal Res 37:425–432

    Article  CAS  PubMed  Google Scholar 

  58. Nelson RG, Shlossman M, Budding LM, Pettitt DJ, Saad MF, Genco RJ, Knowler WC (1990) Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13:836–840

    Article  CAS  PubMed  Google Scholar 

  59. Sconyers JR, Crawford JJ, Moriarty JD (1973) Relationship of bacteremia to tooth brushing in patients with periodontitis. J Am Dent Assoc 87:616–622

    CAS  PubMed  Google Scholar 

  60. Carroll GC, Sebor RJ (1980) Dental flossing and its relationship to transient bacteremia. J Periodontol 51:691–692

    Article  CAS  PubMed  Google Scholar 

  61. Forner L, Larsen T, Kilian M, Holmstrup P (2006) Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 33:401–407

    Article  PubMed  Google Scholar 

  62. Steel DM, Whitehead AS (1994) The major acute phase reactant: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81–88

    Article  CAS  PubMed  Google Scholar 

  63. Chitsazi MT, Pourabbas R, Shirmohammadi A, Ahmadi Zenouz G, Vatankhah AH (2008) Association of periodontal diseases with elevation of serum C-reactive protein and body mass index. J Dent Res Dent Clin Dent Prospects 2:9–14

    PubMed Central  PubMed  Google Scholar 

  64. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221–1227

    Article  CAS  PubMed  Google Scholar 

  65. Bain JL, Lester SR, Henry WD, Bishop CM, Turnage AA, Naftel JP, Johnson RB (2009) Comparative gender differences in local and systemic concentrations of pro-inflammatory cytokines in rats with experimental periodontitis. J Periodontal Res 44:133–140

    Article  CAS  PubMed  Google Scholar 

  66. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 27:1433–1439

    Article  CAS  PubMed  Google Scholar 

  67. Ebersole JL, Cappelli D, Mott G, Kesavalu L, Holt SC, Singer RE (1999) Systemic manifestations of periodontitis in the non-human primate. J Periodontal Res 34:358–362

    Article  CAS  PubMed  Google Scholar 

  68. Lamster IB, Novak MJ (1992) Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 3:31–60

    CAS  PubMed  Google Scholar 

  69. Ranney RR (1991) Immunologic mechanisms of pathogenesis in periodontal disease: an assessment. J Periodontal Res 26:243–254

    Article  CAS  PubMed  Google Scholar 

  70. Kinane DF, Adonogianaki E, Moughal N, Winstanley FP, Mooney J, Thornhill M (1991) Immunocytochemical characteristics of cellular infiltrate, related endothelial changes and determination of GCF acute-phase proteins during human experimental gingivitis. J Periodontal Res 26:286–288

    Article  CAS  PubMed  Google Scholar 

  71. Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26:230–242

    Article  CAS  PubMed  Google Scholar 

  72. Tomofuji T, Azuma T, Kusano H, Sanbe T, Ekuni D, Tamaki N, Yamamoto T, Watanabe T (2006) Oxidative damage of periodontal tissue in the rat periodontitis model: effects of a high-cholesterol diet. FEBS Lett 580:3601–3604

    Article  CAS  PubMed  Google Scholar 

  73. Maruyama T, Tomofuji T, Endo Y, Irie K, Azuma T, Ekuni D, Tamaki N, Yamamoto T, Morita M (2011) Supplementation of green tea catechins in dentifrices suppresses gingival oxidative stress and periodontal inflammation. Arch Oral Biol 56:48–53

    Article  CAS  PubMed  Google Scholar 

  74. Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Maruyama T, Yamamoto T, Watanabe T, Morita M (2011) Relationships between periodontal inflammation, lipid peroxide and oxidative damage of multiple organs in rats. Biomed Res 32:343–349

    Article  CAS  PubMed  Google Scholar 

  75. Karaağaç N, Salman F, Doğru-Abbasoğlu S, Uysal M (2011) Changes in prooxidant-antioxidant balance in tissues of rats following long-term hyperglycemic status. Endocr Res 36:124–133

    Article  PubMed  Google Scholar 

  76. Ekuni D, Endo Y, Irie K, Azuma T, Tamaki N, Tomofuji T, Morita M (2010) Imbalance of oxidative/anti-oxidative status induced by periodontitis is involved in apoptosis of rat submandibular glands. Arch Oral Biol 55:170–176

    Article  CAS  PubMed  Google Scholar 

  77. Nager RM, Salameh F, Reznick AZ, Livshits V, Nahir AM (2003) Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress. Rheumatology (Oxford) 42:1234–1241

    Article  Google Scholar 

  78. Abdollahi M, Fooladian F, Emami B, Zafari K, Bahreini-Moghadam A (2003) Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum Exp Toxicol 22:587–592

    Article  CAS  PubMed  Google Scholar 

  79. de la Cal C, Lomniczi A, Mohn CE, De Laurentiis A, Casal M, Chiarenza A, Paz D, McCann SM, Rettori V, Elverdín JC (2006) Decrease in salivary secretion by radiation mediated by nitric oxide and prostaglandins. Neuroimmunomodulation 13:19–27

    Article  PubMed  Google Scholar 

  80. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Yamamoto T, Morita M (2009) Short-term of non-surgical periodontal treatment on plasma level of reactive oxygen metabolites in patients with chronic periodontitis. J Periodontol 80:901–906

    Article  CAS  PubMed  Google Scholar 

  81. Ekuni D, Tomofuji T, Tamaki N, Sanbe H, Azuma T, Yamanaka R, Yamamoto T, Watanabe T (2008) Mechanical stimulation of gingiva reduces plasma 8-OHdG level in rat periodontitis. Arch Oral Biol 53:324–329

    Article  CAS  PubMed  Google Scholar 

  82. Tomofuji T, Ekuni D, Sanbe T, Azuma T, Tamaki N, Irie K, Maruyama T, Yamamoto T, Watanabe T, Miyauchi M, Takata T (2009) Effects of improvement in periodontal inflammation by tooth brushing on serum lipopolysaccharide concentration and liver injury in rats. Acta Odontol Scand 67:200–205

    Article  CAS  PubMed  Google Scholar 

  83. Tamaki N, Tomofuji T, Ekuni D, Yamanaka R, Morita M (2011) Periodontal treatment decreases plasma oxidized LDL level and oxidative stress. Clin Oral Investig 15:953–958

    Article  PubMed  Google Scholar 

  84. Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrtover MD, Aykac Y, Sozen T (2007) Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med 100:686–691

    Article  Google Scholar 

  85. Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, Seymour GJ (2005) Effects of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 40:53–58

    Article  CAS  PubMed  Google Scholar 

  86. Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, Madianos PN (2006) The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 151:47

    Article  PubMed  Google Scholar 

  87. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, Genco RJ (1997) Treatment of periodontal disease in diabetes reduces glycated hemoglobin. J Periodontol 68:713–719

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichiro Irie .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Irie, K., Ekuni, D., Tomofuji, T., Morita, M. (2014). Periodontitis and Liver Diseases. In: Ekuni, D., Battino, M., Tomofuji, T., Putnins, E. (eds) Studies on Periodontal Disease. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9557-4_14

Download citation

Publish with us

Policies and ethics